Concepedia
Statistics
Publications
92
Citations
5.8K
H-Index
37
Active since
2001
Affiliations
BC Cancer Agency(Current)
University of British Columbia
Princess Margaret Cancer Centre
Mayo Clinic
University of Calgary
Sharlene Gill is an author at BC Cancer Agency specializing in oncology, medicine, and pathology.
Top concepts
MedicineOncologyCancer ResearchPathologyRadiation OncologyColorectal CancerCancer TherapyPharmacologyGastroenterologySurgical Oncology
Publications per year
2001–2025
Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?
Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent et al. · Journal of Clinical Oncology · 2004 · 1K citations
Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna et al. · Journal of Clinical Oncology · 2009 · 642 citations · Full text
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
Sharlene Gill, Yoo‐Joung Ko, C. Cripps et al. · Journal of Clinical Oncology · 2016 · 282 citations
Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer
Aalok Kumar, Hagen F. Kennecke, Daniel J. Renouf et al. · Cancer · 2014 · 175 citations
The Colon Health and Life-Long Exercise Change Trial: A Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group
Kerry S. Courneya, Christopher M. Booth, Sharlene Gill et al. · Current Oncology · 2008 · 169 citations · Full text
1–5 of 92